Equities analysts forecast that Asante Solutions Inc (NASDAQ:PUMP) will report sales of $318.92 million for the current fiscal quarter, Zacks Investment Research reports. Five analysts have issued estimates for Asante Solutions’ earnings, with the lowest sales estimate coming in at $305.00 million and the highest estimate coming in at $338.00 million. The firm is expected to issue its next earnings results on Wednesday, February 7th.
On average, analysts expect that Asante Solutions will report full year sales of $318.92 million for the current year, with estimates ranging from $973.00 million to $1.01 billion. For the next fiscal year, analysts anticipate that the business will report sales of $1.49 billion per share, with estimates ranging from $1.36 billion to $1.60 billion. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that cover Asante Solutions.
PUMP has been the topic of a number of recent research reports. Zacks Investment Research upgraded shares of Asante Solutions from a “hold” rating to a “buy” rating and set a $19.00 price target on the stock in a research report on Friday, November 10th. Royal Bank of Canada set a $24.00 price target on shares of Asante Solutions and gave the stock a “buy” rating in a research report on Thursday, December 21st. SunTrust Banks initiated coverage on shares of Asante Solutions in a research report on Wednesday, December 20th. They set a “buy” rating and a $27.00 price target on the stock. BidaskClub lowered shares of Asante Solutions from a “buy” rating to a “hold” rating in a research report on Thursday, October 26th. Finally, Barclays restated a “hold” rating and set a $18.00 price target on shares of Asante Solutions in a research report on Friday, November 10th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $21.07.
In other Asante Solutions news, major shareholder Energy Capital Partners Ii, Ll sold 13,800,000 shares of Asante Solutions stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $15.07, for a total transaction of $207,966,000.00. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
A number of hedge funds have recently modified their holdings of the business. Exane Derivatives purchased a new stake in shares of Asante Solutions in the 4th quarter valued at approximately $108,000. Quantitative Systematic Strategies LLC purchased a new stake in shares of Asante Solutions in the 4th quarter valued at approximately $329,000. New York State Common Retirement Fund purchased a new stake in shares of Asante Solutions in the 2nd quarter valued at approximately $376,000. California State Teachers Retirement System purchased a new stake in shares of Asante Solutions in the 2nd quarter valued at approximately $625,000. Finally, Teachers Advisors LLC purchased a new stake in shares of Asante Solutions in the 2nd quarter valued at approximately $637,000.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/06/318-92-million-in-sales-expected-for-asante-solutions-inc-pump-this-quarter.html.
Asante Solutions Company Profile
Asante Solutions, Inc is a medical device company. The Company is a manufacturer of Asante Snap Insulin Pump System (Snap system), which is a pump featuring a modular design with pre-filled insulin cartridges and disposable pump bodies, utilized in combination with a controller. The Snap system comprises four components: the Snap system controller, a disposable pump body, disposable pre-filled insulin cartridges and disposable infusion sets.
Get a free copy of the Zacks research report on Asante Solutions (PUMP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Asante Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Asante Solutions and related companies with MarketBeat.com's FREE daily email newsletter.